NEA Management Company’s Marker Therapeutics MRKR Stock Holding History

NEA Management Company’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Hold	1,625,678	–	–	0.15%	23
2026 Q1	$2.11M	Hold	1,625,678	–	–	0.12%	23
2025 Q4	$2.42M	Hold	1,625,678	–	–	0.12%	25
2025 Q3	$1.45M	Hold	1,625,678	–	–	0.08%	27
2025 Q2	$2.49M	Hold	1,625,678	–	–	0.19%	28
2025 Q1	$2M	Hold	1,625,678	–	–	0.15%	33
2024 Q4	$5.06M	Buy	1,625,678 +554,250	+52%	+$1.96M	0.29%	32
2024 Q3	$3.02M	Hold	1,071,428	–	–	0.16%	36
2024 Q2	$5.82M	Hold	1,071,428	–	–	0.44%	33
2024 Q1	$4.61M	Hold	1,071,428	–	–	0.29%	37
2023 Q4	$5.89M	Hold	1,071,428	–	–	0.39%	33
2023 Q3	$4.86M	Hold	1,071,428	–	–	0.38%	34
2023 Q2	$3.32M	Hold	1,071,428	–	–	0.25%	36
2023 Q1	$761K	Sell	1,071,428 -1	-0%	-$2	0.05%	46
2022 Q4	$2.85M	Hold	1,071,429	–	–	0.16%	43
2022 Q3	$3.95M	Hold	1,071,429	–	–	0.2%	47
2022 Q2	$3.54M	Hold	1,071,429	–	–	0.18%	49
2022 Q1	$4.71M	Hold	1,071,429	–	–	0.14%	50
2021 Q4	$10.2M	Hold	1,071,429	–	–	0.21%	45
2021 Q3	$18.1M	Hold	1,071,429	–	–	0.22%	41
2021 Q2	$29.9M	Hold	1,071,429	–	–	0.39%	35
2021 Q1	$24M	Buy	1,071,429 +571,429	+114%	+$13.1M	0.54%	36
2020 Q4	$7.25M	Hold	500,000	–	–	0.19%	51
2020 Q3	$7.5M	Hold	500,000	–	–	0.32%	42
2020 Q2	$10.3M	Hold	500,000	–	–	0.42%	31
2020 Q1	$9.5M	Hold	500,000	–	–	0.5%	30
2019 Q4	$14.4M	Hold	500,000	–	–	0.68%	25
2019 Q3	$25.6M	Hold	500,000	–	–	2.12%	14
2019 Q2	$39.6M	Hold	500,000	–	–	2.77%	13
2019 Q1	$33M	Hold	500,000	–	–	1.71%	16
2018 Q4	$27.8M	Buy	+500,000	New	+$36.4M	1.1%	18

Other funds holding MRKR

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

NEA Management Company's MRKR Position: Q2 2026 in Review

NEA Management Company held its Marker Therapeutics (MRKR) position steady in Q2 2026 at 1,625,678 shares worth $2.39M. The position accounts for 0.15% of the portfolio, ranked #23.

NEA Management Company first reported a position in MRKR in Q4 2018 and has held it in 31 quarters since. The position peaked at $39.6M in Q2 2019. 35 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

NEA Management Company held 1,625,678 shares of Marker Therapeutics worth $2.39M as of Q2 2026.
NEA Management Company left its Marker Therapeutics share count unchanged in Q2 2026.
Marker Therapeutics made up 0.15% of NEA Management Company's portfolio in Q2 2026, its #23 holding.
NEA Management Company first reported a position in Marker Therapeutics in Q4 2018 and has held it in 31 quarters since.
NEA Management Company's Marker Therapeutics position peaked at $39.6M in Q2 2019.
35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on NEA Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.